La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
4013 Aperçu des actions
Sulaiman Al Habib Medical Services Group Company crée, gère et exploite des hôpitaux, des complexes médicaux généraux et spécialisés, des centres de chirurgie d'un jour et des installations pharmaceutiques en Arabie saoudite et à l'étranger.
Score flocon de neige | |
---|---|
Évaluation | 2/6 |
Croissance future | 4/6 |
Performances passées | 3/6 |
Santé financière | 3/6 |
Dividendes | 1/6 |
Dr. Sulaiman Al Habib Medical Services Group Company Concurrents
Historique des prix et performances
Historique des cours de bourse | |
---|---|
Prix actuel de l'action | ر.س300.20 |
Plus haut sur 52 semaines | ر.س346.80 |
Plus bas sur 52 semaines | ر.س223.20 |
Bêta | 0.69 |
1Variation sur 1 mois | -1.12% |
Variation sur 3 mois | 4.02% |
Variation sur 1 an | 27.42% |
3Variation sur 3 ans | 72.53% |
Variation sur 5 ans | n/a |
Évolution depuis l'introduction en bourse | 460.07% |
Nouvelles et mises à jour récentes
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Recent updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27Rendement pour les actionnaires
4013 | SA Healthcare | SA Marché | |
---|---|---|---|
7D | 0.3% | 1.2% | 1.7% |
1Y | 27.4% | 21.6% | -11.3% |
Rendement vs Industrie: 4013 a dépassé le secteur SA Healthcare qui a rapporté 16.9 % au cours de l'année écoulée.
Rendement vs marché: 4013 a dépassé le marché SA qui a rapporté -11.7 % au cours de l'année écoulée.
Volatilité des prix
4013 volatility | |
---|---|
4013 Average Weekly Movement | 2.9% |
Healthcare Industry Average Movement | 4.9% |
Market Average Movement | 4.5% |
10% most volatile stocks in SA Market | 7.8% |
10% least volatile stocks in SA Market | 2.6% |
Cours de l'action stable: 4013 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de 4013 ( 4% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
Fondée | Salariés | PDG | Site web |
---|---|---|---|
1993 | n/a | Faisal Abdullah Al Nassar | www.hmg.com |
Sulaiman Al Habib Medical Services Group Company crée, gère et exploite des hôpitaux, des complexes médicaux généraux et spécialisés, des centres de chirurgie d'un jour et des installations pharmaceutiques en Arabie saoudite et à l'étranger. Elle gère des hôpitaux de maternité, d'orthopédie et de chirurgie rachidienne. Elle gère également des centres de dermatologie, de chirurgie plastique, d'ophtalmologie, de traitement de l'obésité et de fertilité, ainsi que des pharmacies.
Dr. Sulaiman Al Habib Medical Services Group Company Résumé des fondamentaux
4013 statistiques fondamentales | |
---|---|
Capitalisation boursière | ر.س105.07b |
Bénéfices(TTM) | ر.س2.18b |
Recettes(TTM) | ر.س10.02b |
48.3x
Ratio P/E10.5x
Ratio P/SLe site 4013 est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
4013 compte de résultat (TTM) | |
---|---|
Recettes | ر.س10.02b |
Coût des recettes | ر.س6.57b |
Marge brute | ر.س3.45b |
Autres dépenses | ر.س1.27b |
Les revenus | ر.س2.18b |
Derniers bénéfices déclarés
Jun 30, 2024
Prochaine date de publication des résultats
s/o
Résultat par action (EPS) | 6.22 |
Marge brute | 34.42% |
Marge bénéficiaire nette | 21.70% |
Ratio dettes/capitaux propres | 78.6% |
Quelles ont été les performances à long terme de 4013?
Voir les performances historiques et les comparaisons